National Institute of Dental and Craniofacial Research; Notice of Meeting, 51275 [2010-20610]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 160 / Thursday, August 19, 2010 / Notices
Throughout the project period, CDC’s
commitment to continuation of awards
will be conditioned on the availability
of funds, evidence of satisfactory
progress by the recipient (as
documented in required reports), and
the determination that continued
funding is in the best interest of the
Federal government.
Application Selection Process
CDC will apply the same selection
methodology published in the CDC–
RFA–PS10–10138.
Funding Authority
CDC will add the PPACA Authority to
that which is currently reflected in the
published Funding Opportunity CDC–
RFA–PS10–10138. The revised funding
authority language will read:
—This program is authorized under
Sections 301 and 318 of the Public
Health Service Act (42 U.S.C. Section
241 and 247c), as amended, and
Section 4002 of the Patient Protection
and Affordable Care Act (Pub. L. 111–
148).
DATES: The effective date for this action
is August 19, 2010 and remains in effect
until the expiration of the project period
of the PPACA funded applications.
FOR FURTHER INFORMATION CONTACT:
Elmira Benson, Acting Deputy Director,
Centers for Disease Control and
Prevention, 2920 Brandywine Road,
Atlanta, GA 30341, telephone (770)
488–2802, e-mail:
Elmira.Benson@cdc.gov.
On March
23, 2010, the President signed into law
the Patient Protection and Affordable
Care Act (PPACA), Public Law 111–148.
PPACA is designed to improve and
expand the scope of health care
coverage for Americans. Cost savings
through disease prevention is an
important element of this legislation
and PPACA has established a
Prevention and Public Health Fund
(PPHF) for this purpose. Specifically,
the legislation states in Section 4002
that the PPHF is to ‘‘provide for
expanded and sustained national
investment in prevention and public
health programs to improve health and
help restrain the rate of growth in
private and public sector health care
costs.’’ PPACA and the Prevention and
Public Health Fund make improving
public health a priority with
investments to improve public health.
The PPHF states that the Secretary
shall transfer amounts in the Fund to
accounts within the Department of
Health and Human Services to increase
funding, over the fiscal year 2008 level,
for programs authorized by the Public
emcdonald on DSK2BSOYB1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
17:05 Aug 18, 2010
Jkt 220001
Health Service Act, for prevention,
wellness and public health activities
including prevention research and
health screenings, such as the
Community Transformation Grant
Program, the Education and Outreach
Campaign for Preventative Benefits, and
Immunization Programs.
PPACA legislation affords an
important opportunity to advance
public health across the lifespan and to
reduce health disparities by supporting
an intensive community approach to
chronic disease prevention and control.
Therefore, increasing funding
available to applicants under this FOA
using the PPHF to further HIV
prevention programs is consistent with
the purpose of the PPHF, as stated
above, to provide for an expanded and
sustained national investment in
prevention and public health programs.
Further, the Secretary allocated funds to
CDC, pursuant to the PPHF, for the
types of activities this FOA is designed
to carry out.
Dated: August 13, 2010.
Tanja Popovic, MD, PhD, F(AMM),
AM(AAFS),
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
51275
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: September 27, 2010.
Open: 8:30 a.m. to 12:30 p.m.
Agenda: Report of the Director, NIDCR.
Place: National Institutes of Health,
Building 31C, 31 Center Drive, 6th Floor, 10,
Bethesda, MD 20892.
Closed: 1:30 p.m. to Adjournment.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31C, 31 Center Drive, 6th Floor, 10,
Bethesda, MD 20892.
Contact Person: Alicia J. Dombroski, PhD,
Director, Division of Extramural Activities,
National Institute of Dental and Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
[FR Doc. 2010–20572 Filed 8–18–10; 8:45 am]
Dated: August 13, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE P
[FR Doc. 2010–20610 Filed 8–18–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Dental and
Craniofacial Research; Notice of
Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Dental and
Craniofacial Research Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Subcommittee for Planning the Annual
Strategic Plan Updating Process of the
Interagency Autism Coordinating
Committee (IACC). The Subcommittee
meeting will be conducted as a
telephone conference call and webinar.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
National Institute of Mental Health;
Notice of Meeting
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Type of Meeting: Subcommittee for
Planning the Annual Strategic Plan Updating
Process.
Date: September 21, 2010.
Time: 1 p.m. to 3 p.m. Eastern Time.
Agenda: To discuss plans for updating the
IACC Strategic Plan for ASD Research.
Place: No in-person meeting; conference
call and webinar only.
Webinar Access: https://www2.
gotomeeting.com/register/461944091.
Registration: No pre-registration required.
Conference Call: Dial: 800–369–3340.
Access code: 8415008.
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 75, Number 160 (Thursday, August 19, 2010)]
[Notices]
[Page 51275]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-20610]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental and Craniofacial Research; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Dental and Craniofacial Research Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Dental and Craniofacial
Research Council.
Date: September 27, 2010.
Open: 8:30 a.m. to 12:30 p.m.
Agenda: Report of the Director, NIDCR.
Place: National Institutes of Health, Building 31C, 31 Center
Drive, 6th Floor, 10, Bethesda, MD 20892.
Closed: 1:30 p.m. to Adjournment.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31C, 31 Center
Drive, 6th Floor, 10, Bethesda, MD 20892.
Contact Person: Alicia J. Dombroski, PhD, Director, Division of
Extramural Activities, National Institute of Dental and Craniofacial
Research, National Institutes of Health, Bethesda, MD 20892.
Information is also available on the Institute's/Center's home
page: https://www.nidcr.nih.gov/about, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: August 13, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-20610 Filed 8-18-10; 8:45 am]
BILLING CODE 4140-01-P
